NASDAQ:BVXV
BiondVax Pharmaceuticals Ltd.
- Stock
Last Close
1.35
06/09 19:59
Market Cap
4.97M
Beta: 2.47
Volume Today
22.67K
Avg: 41.50K
PE Ratio
0.59
PFCF: −3.53
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 2.75M - | ||||||||||
cost of revenue | |||||||||||
gross profit | 2.75M - | ||||||||||
selling and marketing expenses | -3.72M - | -10.95M - | |||||||||
general and administrative expenses | 3.26M - | 4.06M 24.33% | 4.75M 17.03% | 5.09M 7.16% | 9.35M 83.81% | 16.14M 72.50% | 23.98M 48.61% | ||||
selling general and administrative expenses | 2.19M - | 2.65M 21.00% | 3.26M 23.17% | 4.06M 24.33% | 4.75M 17.03% | 1.37M 71.18% | 9.35M 583.53% | 5.19M 44.52% | 23.98M 362.07% | 5.30M 77.91% | |
research and development expenses | 5.45M - | 5.49M 0.75% | 7.91M 43.95% | 7.79M 1.42% | 18.78M 140.92% | 19.09M 1.69% | 68.64M 259.50% | 16.00M 76.69% | 10.34M 35.39% | 5.76M 44.25% | |
other expenses | 2.19M - | 2.65M 21.00% | 133K 94.98% | 48K 63.91% | 130K 170.83% | 65K 50% | 352K 441.54% | -23.47M 6,768.94% | 509K 102.17% | ||
cost and expenses | 7.64M - | 8.14M 6.56% | 11.30M 38.82% | 11.90M 5.28% | 23.66M 98.79% | 20.46M 13.50% | 78.35M 282.89% | -2.28M 102.91% | 34.83M 1,627.06% | 11.06M 68.24% | |
operating expenses | 7.64M - | 8.14M 6.56% | 11.30M 38.82% | 11.90M 5.28% | 23.66M 98.79% | 20.46M 13.50% | 78.35M 282.89% | -2.28M 102.91% | 34.83M 1,627.06% | 11.06M 68.24% | |
interest expense | 3.61M - | 14.92M 313.24% | 4.86M 67.41% | 10.83M 122.82% | -5.26M 148.61% | ||||||
ebitda | -6.93M - | -7.46M 7.69% | -10.68M 43.00% | -11.28M 5.66% | -12.30M 9.08% | -19.68M 59.99% | -76.86M 290.47% | 3.48M 104.52% | -32.44M 1,033.39% | -10.50M 67.64% | |
operating income | -7.64M - | -8.14M 6.56% | -11.30M 38.82% | -11.90M 5.28% | -23.66M 98.79% | -20.46M 13.50% | -78.35M 282.89% | 1.04M 101.33% | -34.83M 3,449.20% | -11.06M 68.24% | |
depreciation and amortization | 709K - | 677K 4.51% | 628K 7.24% | 621K 1.11% | 440K 29.15% | 260K 40.91% | 1.49M 474.23% | 2.44M 63.16% | 2.38M 2.09% | 562K 76.44% | |
total other income expenses net | -395K - | 378K 195.70% | 1.09M 189.15% | 2.66M 143.46% | -10.91M 510.11% | 2.84M 125.99% | -30.84M 1,187.55% | -2.43M 92.14% | -5.15M 112.30% | 5.26M 202.25% | |
income before tax | -8.04M - | -7.76M 3.38% | -10.20M 31.36% | -9.18M 9.95% | -34.55M 276.21% | -23.29M 32.58% | -109.19M 368.78% | -1.39M 98.73% | -39.98M 2,785.55% | -5.80M 85.50% | |
income tax expense | -11K - | -55K 400% | 10.89M 19,909.09% | 2.88M 73.52% | 14.92M 417.09% | -8.20M 154.97% | 10.83M 232.09% | -5.26M 148.61% | |||
net income | -8.04M - | -7.76M 3.38% | -10.20M 31.36% | -9.18M 9.95% | -34.55M 276.21% | -23.29M 32.58% | -124.11M 432.82% | 6.82M 105.49% | -50.81M 845.54% | -531K 98.95% | |
weighted average shs out | 326.74K - | 326.74K 0% | 263.81K 19.26% | 337.74K 28.03% | 502.58K 48.80% | 653.55K 30.04% | 816.63K 24.95% | 1.11M 35.70% | 1.41M 27.37% | 754.08B 53,425,933.48% | |
weighted average shs out dil | 326.74K - | 326.74K 0% | 263.81K 19.26% | 337.74K 28.03% | 502.58K 48.80% | 653.55K 30.04% | 816.63K 24.95% | 1.11M 35.70% | 1.41M 27.37% | 754.08B 53,425,933.48% | |
eps | -24.59 - | -23.76 3.38% | -38.66 62.71% | -27.19 29.67% | -68.75 152.85% | -35.64 48.16% | -151.98 326.43% | 6.15 104.05% | -36 685.37% | ||
epsdiluted | -24.59 - | -23.76 3.38% | -38.66 62.71% | -27.19 29.67% | -68.75 152.85% | -35.64 48.16% | -151.98 326.43% | 6.15 104.05% | -36 685.37% |
All numbers in USD (except ratios and percentages)